Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 4/2018

01-04-2018 | Original Article

Wide-ranging impacts reported by NZ cancer survivors: is supporting cancer survivor resilience a health sector role?

Authors: Inga O’Brien, Louise Signal, Diana Sarfati

Published in: Supportive Care in Cancer | Issue 4/2018

Login to get access

Abstract

Purpose

Cancer survivor numbers are on the rise but little is known about New Zealand (NZ) survivors’ experiences with management of cancer-related impacts and vulnerability. This study explored the experiences and resilience of NZ cancer survivors and the experiences of healthcare practitioners who work with cancer survivors. There is a focus on indigenous Māori survivors.

Methods

This study used qualitative methods to explore survivors and healthcare practitioners’ views on cancer-related impact and management strategies. Two focus groups were conducted with mainly colorectal cancer survivors residing in the central regions of NZ. There was one Māori-only group (n = 6 participants) and one multicultural group (n = 18 participants). The Māori-only focus group was purposefully organised to provide a culturally safe setting for the research. In addition, 12 in-depth interviews were conducted with healthcare practitioners between October 2011 and March 2012.

Results

Wide-ranging survivorship impacts were described by survivors across physical, emotional, spiritual and social domains. Shame resilience and relationships, particularly with healthcare practitioners, were indicated as useful supports. Healthcare practitioners’ time constraints and role priorities were identified as barriers to their ability to provide survivorship support.

Conclusions

This study generated qualitative data on survivorship impacts and components of survivor resilience in NZ. It also provided insights into the need for better strategies and pathways to help the NZ health system be more responsive to both Māori and non-Māori survivors.

Implications for cancer survivors

Survivor impacts create vulnerabilities that are experienced and described differently by individuals and groups in NZ. Tailored survivor support that can enhance resilience and support relationships is needed in NZ.
Literature
1.
Ministry of Health (2015) Cancer: new registrations and deaths 2012. Ministry of Health, Wellington
2.
Robson B, Purdie G, Cormack D (2010) Unequal impact II: Māori and non-Māori cancer statistics by deprivation and rural–urban status, 2002–2006. Wellington, Ministry of Health
3.
Carter AJR, Nguyen CNA (2012) Comparison of cancer burden and research spending reveals discrepancies in the distribution of research funding. BMC Public Health 12:526CrossRefPubMedPubMedCentral
4.
Hewitt M, Greenfield S, Stoval E (2005) From cancer patient to cancer survivor: lost in transition. National Academies Press, Washington DC
5.
Hofman M, Ryan JL, Figueroa-Moseley CD, Jean-Pierre P, Morrow GR (2007) Cancer-related fatigue: the scale of the problem. Oncologist 12(Suppl 1):4–10CrossRefPubMed
6.
Jones JM, Olson K, Catton P, Catton CN, Fleshner NE, Krzyzanowska MK, McCready DR, Wong RKS, Jiang H, Howell D (2016) Cancer-related fatigue and associated disability in post-treatment cancer survivors. J Cancer Surviv 10:51–61CrossRefPubMed
7.
Hill S, Sarfati D, Blakely T, Robson B, Purdie G, Chen J, Dennett E, Cormack D, Cunningham R, Dew K, McCreanor T, Kawachi I (2010) Survival disparities in indigenous and non-indigenous New Zealanders with colon cancer: the role of patient comorbidity, treatment and health service factors. J Epidemiol Community Health 64:117–123CrossRefPubMed
8.
Hill S, Sarfati D, Blakely T, Robson B, Purdie G, Dennett E, Cormack D, Dew K, Ayanian AZ, Kawachi I (2010) Ethnicity and management of colon cancer in New Zealand. Cancer 116:3205–3214CrossRefPubMed
9.
Blakely T, Shaw C, Atkinson J, Tobias M, Bastiampillai N, Sloane K, Sarfati D, Cunningham R (2012) Cancer trends: trends in incidence by ethnic and socioeconomic group, New Zealand 1981–2004. University of Otago and Ministry of Health, Wellington
10.
Soeberg M, Blakely T, Sarfati D, Tobias M, Costilla R, Carter K, Atkinson J (2012) Cancer trends: trends in cancer survival by ethnic and socioeconomic group, New Zealand 1991–2004. University of Otago and Ministry of Health, Wellington
11.
Walker T, Signal L, Russel M, Smiler K, Tuhiwai-Ruru R, Otaki Community Health Centre, Te Wakahuia Hauora (2008) The road we travel: Maori experiences of cancer. N Z Med J 121:27–35PubMed
12.
O’Brien I, Britton E, Sarfati D, Naylor W, Borman B, Ellison-Loschmann L, Simpson A, Tamblyn C, Atkinson C (2010) The voice of experience: results from cancer control New Zealand’s first national cancer care survey. N Z Med J 123:10–19PubMed
13.
Slater T, Matheson A, Davies C, Tavite H, Ruhe T, Holdaway M, Ellison-Loschmann L (2013) ‘It’s whanaungatanga and all that kind of stuff’: Maori cancer patients’ experiences of health services. J Prim Health Care 5:308–314PubMed
14.
Dew K, Signal L, Davies C, Tavite H, Hooper C, Sarfati D, Stairmand J, Cunningham C (2015) Dissonant roles: the experience of Māori in cancer care. Soc Sci Med 138:144–151CrossRefPubMed
15.
Dew K, Stubbe M, Signal L, Stairmand J, Dennett E, Koea J, Simpson A, Sarfati D, Cunningham C, Batten L, Ellison-Loschmann L, Barton J, Holdaway M (2015) Cancer care decision making in multidisciplinary meetings. Qual Health Res 25:397–407CrossRefPubMed
16.
Ministry of Health and University of Otago (2010) The burden of cancer: New Zealand 2006. Ministry of Health, Wellington
17.
Koczwara B (2015) Cancer survivorship —lessons from around the globe. Cancer Forum 33:83–86
18.
Oeffinger KC, Argenbright KE, Levitt GA, McCabe MS, Anderson PR, Berry E, Maher K, Merrill J, Wollins DS (2014) Models of cancer survivorship health care: moving forward. Am Soc Clin Oncol Educ Book:205–213
19.
Brown B (2006) Shame resilience theory: a grounded theory study on women and shame. Fam Soc J Contemp Soc Serv 87:43–52
20.
21.
Tedeschi RG, Calhoun LG (2004) Posttraumatic growth: conceptual foundations and empirical evidence. Psychol Inq 15:37–41CrossRef
22.
Jefford M, Karahalios E, Pollard A, Baravelli C, Carey M, Franklin J, Aranda S, Schofield P (2008) Survivorship issues following treatment completion-results from focus groups with Australian cancer survivors and health professionals. J Cancer Surviv 2:20–32CrossRefPubMed
23.
Baravelli C, Krishnasamy M, Pezaro C, Schofield P, Lotfi-Jam K, Rogers M, Milne D, Aranda S, King D, Shaw B, Grogan S, Jefford M (2009) The views of bowel cancer survivors and health care professionals regarding survivorship care plans and post treatment follow up. J Cancer Surviv 3:99–108CrossRefPubMed
24.
De Moor JS, Mariotto AB, Parry C, Alfano CM, Padgett L, Kent EE, Forsythe L, Scoppa S, Hachey M, Rowland JH (2013) Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care. Cancer Epidemiol Biomark Prev 22:561–570CrossRef
25.
Sarfati D, Koczwara B, Jackson C (2016) The impact of comorbidity on cancer and its treatments. CA Cancer J Clin 66:337–350CrossRefPubMed
26.
Aziz NM (2007) Cancer survivorship research: state of knowledge, challenges and opportunities. Acta Oncol 46:417–432CrossRefPubMed
27.
28.
Durie M (1994) Waiora: Maori health development. Oxford University Press, Oxford
29.
Metge J (1995) New growth from old: the whanau in the modern world. Victoria University Press, Wellington
30.
Central Cancer Network NZ (2016) He anga whakaahuru: supportive care framework. Central Cancer Network, Palmerston North
31.
32.
Koea JB (2008) Ghosts in the machine: the experiences of Māori in the New Zealand health system. N Z Med J 121:27–35
33.
Egan R, Doherty J, Albert T, Llewellyn R, Walsh C, Kerslake P, Pihema C, Kramer J, Frost A, Retimanu-Pule M, Atkinson K, Sutcliffe S, Olsen T, Atkinson C, McGrath P, Wood S, Stacy-Baynes S, Daly M (2014) He kahui korero taumahatanga o te mate pukupuku: cancer stories project Aotearoa/New Zealand. University of Otago and Cancer Society of New Zealand, Dunedin
34.
Ohlsson-Nevo E, Andershed B, Nilsson U, Anderzén-Carlsson A (2012) Life is back to normal and yet not—partners’ and patient’s experiences of life of the first year after colorectal cancer surgery. J Clin Nurs 21:555–563CrossRefPubMed
35.
Richardson A, Addington-Hall J, Amir Z, Foster C, Stark D, Armes J, Brearley SG, Hodges L, Hook J, Jarrett N, Stamataki Z, Scott I, Walker J, Ziegler L, Sharpe M (2011) Knowledge, ignorance and priorities for research in key areas of cancer survivorship: findings from a scoping review. Br J Cancer 105(Suppl):S82–S94CrossRefPubMedPubMedCentral
36.
Klimmek R, Wenzel J (2012) Adaptation of the illness trajectory framework to describe the work of transitional cancer survivorship. Oncol Nurs Forum 39:E499–E510CrossRefPubMedPubMedCentral
37.
Murray CJL, Evans DB (2003) Health systems performance assessment: debates, methods and empiricism. World Health Organisation, Geneva
Metadata
Title
Wide-ranging impacts reported by NZ cancer survivors: is supporting cancer survivor resilience a health sector role?
Authors
Inga O’Brien
Louise Signal
Diana Sarfati
Publication date
01-04-2018
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 4/2018
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-017-3943-x

Other articles of this Issue 4/2018

Supportive Care in Cancer 4/2018 Go to the issue

Original Article

A prospective, multicenter pilot study to investigate the feasibility and safety of a 1-year controlled exercise training after adjuvant chemotherapy in colorectal cancer patients

Original Article

Prevalence and correlates of health information-seeking among Hispanic and non-Hispanic childhood cancer survivors

Original Article

Oncology navigators’ perceptions of cancer-related financial burden and financial assistance resources

Original Article

Costs from a healthcare and societal perspective among cancer patients after total laryngectomy: are they related to patient activation?

Original Article

Unmet support needs of sexual and gender minority breast cancer survivors

Original Article

Patients with advanced periodontal disease before intensity-modulated radiation therapy are prone to develop bone healing problems: a 2-year prospective follow-up study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits